IFN-γ fails to antagonize fibrotic effect of TGF-β on keloid-derived dermal fibroblasts

Journal of Dermatological Science

Volumn 32, Issue 1, 2003, Pages 19-24

  Hasegawa, Toshio ^a   Nakao, Atsuhito ^a   Sumiyoshi, Koji ^a   Tsuboi, Ryoji ^a   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibroblasts; IFN ; Keloid; TGF

Indexed keywords

ALPHA ACTIN; ANTIFIBROTIC AGENT; COLLAGEN TYPE 1; GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BIOASSAY; CELL ACTIVITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; INHIBITION KINETICS; KELOID; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKIN CELL; SKIN FIBROBLAST; SKIN FIBROSIS; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTION; WESTERN BLOTTING;

EID: 0037533688     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(03)00044-6     Document Type: Article

References (29)

1. Murry J.C., Pollack S.V., Pinnelli S.R. Koloids: a review. J. Am. Acad. Dermatol. 4:1981;461-470.
2. Border W.A., Noble N. Transforming growth factor-β in tissue fibrosis. New Engl. J. Med. 331:1994;1286-1292.
3. Verrecchia F., Mauviel A. Transforming growth factor-β signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J. Invest. Dermatol. 118:2002;211-215.
4. Peltonen J., Hsiao L.L., Jaakkola S., Sollberg S., Aumailley M., Timpl R., Chu M.L., Uitto J. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-β1 mRNA. J. Invest. Dermatol. 97:1991;240-248.
5. Babu M., Diegelmannn R., Oliver N. Keloid fibroblasts exhibit an altered response to TGF-β J. Invest. Dermatol. 99:1992;650-655.
6. Lee T.Y., Chin G.S., Kim W.J., Chau D., Gittes G.K., Lingaker M.T. Expression of transforming growth factor-β1, 2, 3 proteins in keloids. Ann. Plast. Surg. 82:1999;319-323.
7. Chin G.S., Liu W., Peled Z., Lee T.Y., Steinbrech D.S., Hsu M., Longaker M.T. Differential expression of transforming growth factor-β receptors I and II and activation of Smad3 in keloid fibroblasts. Plast. Reconstr. Surg. 108:2001;423-429.
8. Bettinger D.A., Yager D.R., Diegelmann R.F., Cohen U.K. The effect of TGF-β on keloid fibroblast proliferation and collagen synthesis. Plast. Reconstr. Surg. 98:1996;827-833.
9. Kikuchi K., Kadono T., Takehara K. Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology. 190:1995;4-8.
10. Mikulec A.A., Hanasono M.M., Lum J., Kadleck J.M., Kita M., Koch R.J. Effect of tamoxifen on transforming growth factor-β1 production by keloid and fetal fibroblasts. Arch. Facial Plast. Surg. 3:2001;111-114.
11. Chau D., Mancoll J.S., Lee S., Zhao J., Phillips L.G., Gittes G.K., Longaker M.T. Tamoxifen downregulates TGF-β production in keloid fibroblasts. Ann. Plast. Surg. 40:1998;490-493.
12. Adelmann-Grill B.C., Hein R., Wach F., Krieg T. Inhibition of fibroblast chemotaxis by recombinant human IFN-α and -α J. Cell Physiol. 130:1987;270-275.
13. Elias J.A., Jimennez S.A., Freundilish B. Recombinant γ-, α-, and β-interferon regulation of human lung fibroblast proliferation. Am. Rev. Respir. Dis. 135:1987;62-65.
14. Varga J., Olsen A., Herhal J., Constantine G., Rosenbloom J., Jimenez S.A. Interferon-γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-β in normal human fibroblasts. Eur. J. Clin. Invest. 20:1990;487-493.
15. Ghosh A.K., Yuan W., Mori Y., Chen S., Varga J. Antagonistic regulation of type I collagen gene expression by IFN-γ and TGF-β: integration at the level of p300/CBP transcriptional coactivators. J. Biol. Chem. 276:2001;11041-11048.
16. Ulloa L., Doody J., Massague J. Inhibition of transforming growth factor-β/SMAD signaling by the interferon-γ/STAT pathway. Nature. 397:1999;710-713.
17. Baroni G.S., D'Ambrosio L., Curto P., Casini A., Mancini R., Jezequel A.M., Benedetti A. IFN-γ decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology. 23:1996;1189-1199.
18. Oldroyd S.D., Thomas G.L., Gabbiani G., El Nahas A.M. Interferon-γ inhibits experimental renal fibrosis. Kidney Int. 56:1999;2116-2127.
19. Lee Y.R., Oshita Y., Tsuboi R., Ogawa H. Combination of insulin-like growth factor (IGF)-1 and IGF-binding protein-1 promotes fibroblast-embedded collagen gel contraction. Endocrinology. 137:1996;5278-5283.
20. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J.I., Heldin C.H., Miyazono K., ten Dijke P. TGF-β receptor mediated signaling through Smad2, Smad3, and Smad4. EMBO J. 16:1997;5353-5362.
21. Suhr K.B., Tsuboi R., Ogawa H. Sphingosylphosphorylcholine stimulates contraction of fibroblast-embedded collagen gel. Br. J. Dermatol. 143:2000;66-71.
22. Phipps S., Ying S., Wangoo A., Ong Y.E., Levi-Schaffer F., Kay A.B. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J. Immunol. 169:2002;4604-4612.
23. Grinnel F. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124:1994;401-404.
24. Montesano R., Orci L. Transforming growth factor-β stimulates collagen-matrix contraction by fibroblasts: implication for wound healing. Proc. Natl. Acad. Sci. USA. 85:1988;4894-4897.
25. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122:1993;103-111.
26. Desmouliere A., Rubbia-Brandt L., Abdiu A., Walz T., Macieira-Coelho A., Gabbiani G. α-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by γ-interferon. Exp. Cell Res. 201:1992;64-73.
27. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., Chaponnier C. α-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell. 12:2001;2730-2741.
28. Yokozeki M., Baba Y., Shimokawa H., Moriyama K., Kuroda T. Interferon-γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-β1 in vitro. FEBS Lett. 442:1999;61-64.
29. Granstein R.D., Rook A., Flotte T.J., Haas A., Gallo R.L., Jaffe H.S., Amento E.P. A controlled trial of intralesional recombinant interferon-γ in the treatment of keloidal scarring. Clinical and histologic findings. Arch. Dermatol. 126:1990;1295-1302.